Lipum AB
LIPUM | FN
Overview
Corporate Details
- ISIN(s):
- SE0015660899 (+1 more)
- LEI:
- 549300V7JL0004BHBD93
- Country:
- Sweden
- Address:
- Tvistevägen 48 C, 907 36 Umeå
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Lipum AB develops innovative treatments for chronic inflammatory diseases. Their lead drug candidate targets rheumatoid arthritis.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-14 | Peter Hovstadius | Other | Sell | 2,000 | 28,260.00 SEK |
| 2025-04-14 | Peter Hovstadius | Other | Sell | 1,500 | 22,770.00 SEK |
| 2025-04-14 | Peter Hovstadius | Other | Sell | 1,500 | 21,030.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
European Institute of Science AB | Sweden | EURI B | |
|
European Medical Solutions | Belgium | ALEMS | |
|
Evogene Ltd. | Israel | EVGN | |
|
Evolva Holding SA | Switzerland | EVE | |
|
EXACT Therapeutics AS | Norway | EXTX | |
|
Exosens | France | EXENS | |
|
ExpreS2ion Biotech Holding AB | Sweden | EXPRS2 | |
|
Fermentalg | France | ALGAE | |
|
Formycon AG | Germany | FYB | |
|
FRONTIER IP GROUP PLC | United Kingdom | FIPP |